Vaccines, recombinant protein preparations, and other high-viscosity fluids that are difficult to filter are ideal for filtration sterilization.
The Supor(R) EX ECV filter combines a unique membrane configuration with a laid-over pleat structure and narrow core design, offering both high processing capacity and flow characteristics. With excellent pH compatibility and high permeability for the active ingredient, protein, it is an optimal filtration sterilization grade filter (0.2 μm) for liquids that are difficult to filter. 【Features】 - Composed of a two-layer hydrophilic polyethersulfone (PES) membrane *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Other Features】 - With 2D data matrix mark - Usable with electronic devices *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.